Login / Signup

Differences in hearing recovery following intratympanic alone or intravenous dexamethasone with rescue intratympanic steroids for sudden sensorineural hearing loss: A randomised trial.

Jie HuangLi YangXihong CaoWuqing Wang
Published in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2021)
IT dexamethasone was safer than IV dexamethasone, and there was no evidence of a difference in hearing outcomes between IT dexamethasone and sequential IV plus IT treatments. It is necessary to make individualised treatment decisions according to the patient's condition.
Keyphrases
  • high dose
  • low dose
  • hearing loss
  • study protocol
  • metabolic syndrome
  • insulin resistance
  • replacement therapy
  • glycemic control